ATLASSana Biotechnology (SANA) earnings date: Nov 5, 2026
Sana Biotechnology (SANA) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$0.18.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on SANA
| Last price | $2.39 (-7.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.4% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Sana Biotechnology stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Sana Biotechnology reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Sana Biotechnology. You can switch it off at any time.
Alert me before SANA reportsFree to start. Creating an account takes under a minute.
Notify me when Sana Biotechnology reports
Track SANA free Add Sana Biotechnology to a free ATLAS watchlist and see its next report date in one place.
SANA earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.18 |
| Last report | Aug 10, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -1.4% |
| Average move around a report | ±6.3% (last 5) |
| Sector | Healthcare · Biotechnology |
Sana Biotechnology earnings history: last 5 reports
Sana Biotechnology last reported on Aug 10, 2026: EPS of -$0.13 against an estimate of -$0.12 (-8.3% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$0.12 | -$0.13 | -8.3% | Miss | +7.7% |
| Jul 23, 2026 | $3.32 | $3.52 | +6.0% | Beat | +1.9% |
| May 11, 2026 | -$0.15 | -$0.14 | +6.7% | Beat | -7.1% |
| May 4, 2026 | $0.78 | $0.87 | +11.5% | Beat | +6.7% |
| Mar 3, 2026 | -$0.13 | -$0.16 | -23.1% | Miss | -8.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for SANA
See the fair value, the probability range and the earnings history of Sana Biotechnology on its ATLAS page.
Sana Biotechnology (SANA) stock analysisPlans from €3.99 a month.
Sana Biotechnology earnings: frequently asked questions
When does Sana Biotechnology (SANA) report earnings?
Sana Biotechnology is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for SANA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.18 per share (USD). Estimates can change before the report.
How often does SANA beat earnings estimates?
Of its last 5 reports with a recorded result, Sana Biotechnology beat the EPS estimate 3 times; the average surprise was -1.4%. Past results do not predict the next one.
How much does SANA move around earnings?
Over its last 5 reports the stock moved an average of 6.3% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Sana Biotechnology beat earnings estimates last quarter?
Sana Biotechnology last reported on Aug 10, 2026: EPS of -$0.13 against an estimate of -$0.12 (-8.3% surprise), a miss.
How much does SANA usually move in a day?
On a normal trading day the ATLAS model puts SANA’s one-day range at about ±4.4%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer